AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17609429
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Miglustat + Imiglucerase)
Trial: 16373264
Drug: ACIST injection
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACIST injection system (n=252)
Trial: 2649122
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine 0.5 mg
Trial: 17617287
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg packet (sachet) formulation
Trial: 11773946
Drug: Biologic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologic therapies (anti-tumour necrosis factor-alpha, interleukin-10, interleukin-11, anti-integrin antibody, antisense intercellular adhesion molecule-1 oligonucleotide)
Trial: 11122690
Drug: Lovastatin therapy
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin therapy
Trial: 15345500
Drug: naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 500 mg twice daily
Trial: 12521407
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine patch
Trial: 20639026
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg serlopitant
Trial: 20639026
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg serlopitant
Trial: 31087047
Drug: Community treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community treatment orders
Trial: 19844249
Drug: Early initiation
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Early initiation of estrogen therapy
Trial: 16647134
Drug: Pegaptanib sodium
RxNorm normalized name: Pegaptanib Sodium
DrugBank: Pegaptanib (DB04895)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegaptanib sodium (0.3 mg)
Trial: 2991475
Drug: Intravenous hyperalimentation
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hyperalimentation (IVH)
Trial: 30895944
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol plus 5‐fluorouracil (5‐FU)
Trial: 7727328
Drug: Isobaric tetracaine
RxNorm normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isobaric tetracaine (IT) at varying doses and volumes
Trial: 17908628
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy combined with chemotherapy
Trial: 17938794
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (CI) of rFVIIa (50 microg/kg/h through day 5, then 25 microg/kg/h for days 6-10)
Trial: 11386894
Drug: Warfarin in
RxNorm normalized name: warfarin Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin in randomized trials
Trial: 25575246
Drug: EW nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EW nebulizer with 30-second inhalation
Trial: 9347673
Drug: Ketoprofen hydroalcoholic
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen hydroalcoholic gel, applied at the painful site four times a day for 4 weeks
Trial: 8212152
Drug: Short taper
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short taper group (total PRED dose of 2275 mg/m2 over 86 days)
Trial: 8212152
Drug: Long taper
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long taper group (total PRED dose of 6300 mg/m2 over 147 days)
Trial: 19828484
Drug: High magnesium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High magnesium levels (>1.0 mmol/l)
Trial: 26689783
Drug: Rivaroxaban in
RxNorm normalized name: Product containing rivaroxaban in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban in combination with aspirin plus clopidogrel or with aspirin alone
Trial: 22732511
Drug: Antibiotics plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics plus albumin (1.5 g/kgbw at diagnosis and 1 g/kgbw at day 3); n=56
Trial: 31894027
Drug: Valsartan dispersible
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan dispersible tablets
Trial: 31894027
Drug: Nifedipine controlled-release
RxNorm normalized name: nifedipine Extended Release Oral Tablet [Afeditab CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine controlled-release tablets combined with valsartan
Trial: 16141376
Drug: H2-receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonist (300 mg oral ranitidine)
Trial: 24670148
Drug: Paromomycin-miltefosine combination
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paromomycin-miltefosine combination therapy
Trial: 2254102
Drug: Classical radiation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classical radiation therapy (IC) - 45 Gy in 25 fractions over 33 days
Trial: 1320919
Drug: Intravenous granisetron
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous granisetron 40 micrograms/kg
Trial: 8429117
Drug: Nizatidine 150
RxNorm normalized name: nizatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 150 mg bid
Trial: 8429117
Drug: Nizatidine 300
RxNorm normalized name: nizatidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 300 mg bid
Trial: 25323890
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate (NaP) tablets
Trial: 1843963
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol (PEG) solution
Trial: 22960196
Drug: GIP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIP infusion [2.0 pmol kg(‐1) min(‐1) for 240 min]
Trial: 25609246
Drug: Ganitumab 12
RxNorm normalized name: Ganitumab
DrugBank: Ganitumab (DB12205)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganitumab 12 mg/kg
Trial: 8035693
Drug: Blocked lists
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blocked lists of color patches
Trial: 15834325
Drug: Information Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information Group (nonelastic sacroiliac belt and oral/written information about pelvic girdle pain)
Trial: 7001898
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment group.
Trial: 28884732
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (n=44)
Trial: 12048134
Drug: Pitavastatin 4
RxNorm normalized name: PITAVASTATIN 4MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 4 mg/day for up to 104 weeks
Trial: 25688120
Drug: Dose-dense temozolomide
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dose-dense temozolomide
Trial: 2151435
Drug: Picotamide 300
RxNorm normalized name: picotamide
DrugBank: Picotamide (DB13327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide 300 mg t.i.d. for 10 days
Trial: 15631278
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (CC) 16 mg plus hydrochlorothiazide (HCTZ) 12.5 mg
Trial: 11603446
Drug: Magnesium infusion
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium infusion (6 mmol MgSO4 in 100 mL 0.9% NaCl solution, 25 mL/h) administered the day before surgery, just after cardiopulmonary bypass, and once daily for 4 days after surgery
Trial: 10994682
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy integrated into Day Treatment Program (CBT/DTP)
Trial: 21656058
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) intervention
Trial: 30409942
Drug: CPP-ACP chewing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CPP-ACP chewing gums, used thrice daily for 2 weeks
Trial: 11450504
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg gliclazide (study 1)
Trial: 8642959
Drug: Introduction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Introduction of artemisinin derivatives in routine treatment
Trial: 22917822
Drug: Landiolol hydrochloride
RxNorm normalized name: Landiolol Hydrochloride
DrugBank: Landiolol (DB12212)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Landiolol hydrochloride (1 μg/kg per minute after cardiopulmonary bypass or after distal anastomoses)
Trial: 9364700
Drug: Separate administration
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate administration of DTPa and HBV vaccines
Trial: 10495460
Drug: Deferred zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deferred zidovudine treatment
Trial: 24834504
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + MTZ (400 mg TID)
Trial: 17560876
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin plus planned glycoprotein IIb/IIIa inhibitor
Trial: 10051803
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (360 mg Mg/day)
Trial: 31626835
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment program focused on parenting skills (10 weekly sessions)
Trial: 11282170
Drug: 6-methylprednisolone therapy
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6-methylprednisolone therapy
Trial: 25527661
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake ranging from 0.22 to 2.56 g · kg(‐1) · d(‐1) during early gestation.
Trial: 29699852
Drug: SC injection
RxNorm normalized name: SC 41930
DrugBank: SC 41930 (DB17101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC injection
Trial: 7259512
Drug: Intravenous calcium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous calcium chloride (5 mg/kg intermittent IV bolus)
Trial: 31726894
Drug: Intratumoral injection
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intratumoral injection of DNX-2401 without tumor resection
Trial: 29167980
Drug: Percutaneous platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous platelet concentrate (PC) injection
Trial: 7587851
Drug: Multiple insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple insulin injection therapy (MIT)
Trial: 15982350
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of influenza vaccine
Trial: 16785774
Drug: High-intensity light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity light treatment
Trial: 17301956
Drug: Intravenous carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous carboplatin
Trial: 111886
Drug: Low-dose continuous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose continuous intravenous insulin infusion
Trial: 21419776
Drug: Revaccination of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revaccination of horses with low antibody levels
Trial: 8299786
Drug: 0.05 mg
RxNorm normalized name: biotin 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg transdermal 17 beta‐E2
Trial: 21570487
Drug: Exercise combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise combined with vitamin D and calcium supplements
Trial: 6262702
Drug: Tiapride infusion
RxNorm normalized name: tiapride
DrugBank: Tiapride (DB13025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapride infusion
Trial: 26613214
Drug: Early prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early prophylactic INSURE with surfactant administration immediately after birth
Trial: 27801404
Drug: Biological feedback
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological feedback (BFB) technique
Trial: 20811658
Drug: 21 mg
RxNorm normalized name: aspirin 421 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg NRT
Trial: 20811658
Drug: 42 mg
RxNorm normalized name: lithium 42 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 mg NRT
Trial: 15844708
Drug: Peginterferon alpha-2a
RxNorm normalized name: PEGINTERFERON ALPHA-2A 180MCG/ML INJ,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alpha-2a plus ribavirin (180 microg peg‐interferon alpha‐2a + 800-1000 mg/day ribavirin)
Trial: 26985045
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with saline infusion
Trial: 8644661
Drug: Enalapril and
RxNorm normalized name: enalapril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril and loop diuretics with or without digoxin
Trial: 8522052
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (initial dose of 7.2 +/- 0.1 mg.kg-1.day-1, decreased stepwise and interrupted after 6-62 months)
Trial: 7556743
Drug: Tropicamide Novel
RxNorm normalized name: Tropicamide
DrugBank: Tropicamide (DB00809)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tropicamide Novel Ophthalmic Delivery System (NODS) and guttae phenylephrine 10% applied once, 2 hours before surgery
Trial: 8678384
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate lozenges
Trial: 22302316
Drug: Intra-articular betamethasone
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-articular betamethasone injections
Trial: 28039583
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g D-chiro-inositol plus 400 mcg folic acid once daily
Trial: 2882772
Drug: Buccal nitroglycerine
RxNorm normalized name: nitroglycerin Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal nitroglycerine (10 mg)
Trial: 2882772
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of celiprolol and nitroglycerine
Trial: 23272985
Drug: Depression treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depression treatment (received by 168 patients)
Trial: 3609190
Drug: Lower tar
RxNorm normalized name: Coal Tar
DrugBank: Coal tar (DB11082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower tar cigarette (10 mg tar, 1.4 mg nicotine)
Trial: 792359
Drug: Amikacin plus
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin plus penicillin G (Amik-Pen)
Trial: 792359
Drug: Combined antibiotics
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antibiotics without demonstrated synergy in vitro
Trial: 9200048
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser and deep friction massage twice a week for 3 weeks
Trial: 23313654
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza vaccine then Tdap-IPV 28‐35 days later (Group 2)
Trial: 16088297
Drug: Balsamodendron mukul
RxNorm normalized name: COMMIPHORA MUKUL (GUGGUL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balsamodendron mukul (1.5 g/d)
Trial: 151476
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion with saline
Trial: 31571243
Drug: Immediate periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate periodontal therapy (test group, n=46)
Trial: 7746398
Drug: Neutral drug
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral drug group (n = 59)
Trial: 30029204
Drug: Interactive Metronome
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive Metronome (IM) training, 35-40 min per session, twice a week for 6 weeks
Trial: 24144243
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light and melatonin capsules
Trial: 17519150
Drug: Extended oral
RxNorm normalized name: Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended oral contraceptive regimen containing 3 mg drosperinone and 30 microg ethinyl estradiol
Trial: 16860046
Drug: 3-day hormone-free
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-day hormone-free interval (HFI)
Trial: 16342193
Drug: Granulocyte colony
RxNorm normalized name: Granulocyte colony stimulating factor
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Granulocyte colony stimulating factor (G‐CSF, 5 microg/kg/day) administered subcutaneously for 5 days for mobilization of CD34(+) cells.
Trial: 23596262
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of praziquantel (40 mg/kg body weight)
Trial: 15173537
Drug: Nasal continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal continuous positive airway pressure (NCPAP) after surfactant administration (SURF‐NCPAP group)
Trial: 28831951
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein concentrate (PRO, 4×20 g on exercise day and 20 g/d for the following 8 days)
Trial: 25948101
Drug: Dasotraline 8
RxNorm normalized name: Dasotraline
DrugBank: Dasotraline (DB12305)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasotraline 8 mg/day
Trial: 10686660
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg orally daily for 10 days
Trial: 25875257
Drug: Aerosolized vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized vaccine
Trial: 11316646
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg NCS
Trial: 11316646
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg NCS
Trial: 28555052
Drug: New Zealand
RxNorm normalized name: NEW ZEALAND GREEN MUSSEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Zealand blackcurrant (NZBC) extract (600 mg∙day‐1 CurraNZ™)
Trial: 7817618
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lisinopril once daily